US-based company that deals with human-centred medical device development and regulatory services ClariMed, Inc. announced on Wednesday that it is opening its new office in Leeds, UK.
This move is intended to strengthen the company's European footprint and improve its ability to serve global customers while capitalising on the region's thriving healthcare innovation ecosystem.
The company says that the Leeds office is to serve as a hub for its expanding medical device user research capabilities, providing access to a diverse pool of study participants and enriching the firm's human factors engineering insights. It is to also function as a research facility to host usability and human factors studies to support design development, market research and human factors assessments.
Kelley Kendle, ClariMed CEO, said, 'This expansion not only broadens our geographical reach but also allows us to tap into the region's rich talent pool and innovative spirit. Leeds' strategic location and thriving healthcare sector align perfectly with our mission to drive human-centred innovation in medical device development.'
TFF Pharmaceuticals partners on dry powder inhaled mRNA treatment
Merck's GARDASIL 9 shows promise in preventing HPV infection in Japanese males
Solu Therapeutics names new chief medical officer
Arecor reports positive Phase I Results for AT278 insulin at EASD 2024
Dupixent shows promise in treating chronic spontaneous urticaria
Carisma and Moderna expand collaboration
Active Biotech reports promising results for laquinimod eye drops
Phanes Therapeutics doses first subject in clinical study of PT886 in combination with chemotherapy
Eli Lilly and Company names new EVP and CFO
AbbVie advances solid tumour pipeline with new data at ESMO 2024
Amgen showcases promising data for IMDELLTRA in small cell lung cancer at WCLC 2024
Terns Pharmaceuticals reports positive Phase 1 data for TERN-601
Diamyd Medical seeks Fast-Track approval for Type 1 Diabetes immunotherapy